Search Medical Condition
Please enter condition
Please choose location

Diabetes and Hypertension Clinical Trials

A listing of Diabetes and Hypertension medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (49) clinical trials

A 8 to 12 Week Randomized, Double-Blind Study to Compare the Fixed-Dose Combination of Telmisartan 80 + Amlodipine 10mg Versus Amlodipine 10mg Monotherapy as First Line Therapy in Type 2 Diebetes Patients with Hypertension (High Blood Pressure) Patient Inclusion Criteria: Men or Women 18 Years of Age or Older May ...

Phase

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Phase 3 Trial to Evaluate the Safety and Efficacy of xxxxxxxxx in Subjects with Type 2 Diabetes with Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor (ACEI) or Angiotensin Receptor Blocker (ARB) Patient Inclusion Criteria: Subjects must be willing and able to give ...

Phase

People with these conditions have a higher risk of heart attack or stroke in the future. Because we know who is at a greater risk, we want to take early steps to try to prevent a cardiovascular emergency. The Aleprevent clinical research study will look at whether an investigational medication ...

Phase N/A

Dapagliflozin Effect on Cardiovascular Events A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Effect of Dapagliflozin 10 mg Once Daily on the Incidence of Cardiovascular Death, Myocardial Infarction or Ischemic Stroke in Patients With Type 2 Diabetes Inclusion Criteria: Provision of informed consent prior to any study specific procedures ...

Phase

The primary objective of this study will be to evaluate the effect of EQW, used in addition to the current usual care for glycemic control, on major macrovascular events when administered to patients with type 2 diabetes.

Phase

This clinical trial is provided by Antidote. This research study is evaluating a new investigational medicine for patients with type 2 diabetes and severe or end-stage kidney disease. Current treatment options for such patients are limited. The study medicine is being evaluated to see if it can improve the management ...

Phase

If you are at least 18 years of age and have been taking insulin for at least 6 months, you may qualify to participate in the clinical research study of an investigational anti-diabetes medication to evaluate its effect on blood sugar levels.

Phase N/A

What are the FIDELIO-DKD and FIGARO-DKD studies? The FIDELIO-DKD and FIGARO-DKD studies are clinical research studies for adults with type 2 diabetes and diabetic kidney disease (DKD). The purpose of the studies is to evaluate whether adding an investigational medication to regular treatment may be safe and effective to help ...

Phase

Type 2 Diabetes? Currently using Insulin? Such as Levemir ®, Lantus®, Humulin N®, Novolin N®, Basaglar®, or other long- acting insulin You may be eligible to participate in a 58 week Research Study if you are: Diagnosed with Type 2 Diabetes Currently using insulin Age 18 or older ClinicalTrials.gov Identifier: ...

Phase

Registry Trial of the Effectiveness of Platelet Rich Plasma for Chronic Non-Healing Wounds

The proposed investigation is designed to solicit a large number of patients (N=1,500) with non-healing wounds (Diabetic Foot Ulcers, Venous Ulcers, or Pressure Ulcers) that have not responded to standard wound care in the previous 30 days or more. A prospective, interventional, single-blinded, controlled, registry trial will be used. Data ...

Phase N/A